Does Medicare pay for acupuncture?

Translate to Spanish or other 102 languages!

Medicare Part B currently fundsĀ up to 12 sessionsĀ of acupuncture treatment for those with chronic lower back pain. Image for illustration purposes
Medicare Part B currently fundsĀ up to 12 sessionsĀ of acupuncture treatment for those with chronic lower back pain. Image for illustration purposes
- Advertisement -

Medical News Today

According to the National Center for Complementary and Integrative HealthTrusted Source, acupuncture can help soothe neck and lower back pain and discomfort due to osteoarthritis and knee pain. 

People might also benefit from the effects of acupuncture if they have migraine headaches. 

- Advertisement -

Medicare Part B currently funds up to 12 sessions of acupuncture treatment for those with chronic lower back pain. The insured individual will need to pay 20% of the fee that Medicare approves for coverage.

Follow the link below to read the full story on Medical News Today:

https://www.medicalnewstoday.com/articles/does-medicare-cover-acupuncture?utm_term=feedcontent&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-06-05&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Study: Supplement Plus Chemo Boosts Pancreatic Cancer Survival

L-glutamine, an amino acid that occurs naturally in the body and plays an important role in digestion, has been studied as a potential way to ease side effects in other cancers.

How Artificial Intelligence Is Improving Prostate Cancer Diagnostics

Mega Doctor News CLEVELAND CLINIC - September is Prostate Cancer Awareness Month.  Prostate cancer is...

New Strategies to Soothe Dry Eyes

Anyone who has ever endured burning, itchy eyes or extra tearing knows that these symptoms are tough to ignore.

FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder

The U.S. Food and Drug Administration today approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare blood disorder that causes the body to make too many red blood cells.
- Advertisement -